Manufacturer
32 recalls in our database name Hartley Medical Center Pharmacy, Incorporated as the manufacturing or recalling firm.
Of the 32 recalls from Hartley Medical Center Pharmacy, Incorporated we have scored against our rubric, 1 (3%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 30 (94%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Hartley Medical Center Pharmacy is recalling Morphine Sulfate and Bupivacaine HCL syringes due to a lack of assurance of sterility.
Hartley Medical Center Pharmacy is recalling Hydromorphone HCL and Bupivacaine HCL syringes due to a lack of assurance of sterility.
Hartley Medical Center Pharmacy is recalling Morphine Sulfate 11 mg/ml syringes due to a lack of assurance of sterility. The product was distributed nationwide.
Hartley Medical Center Pharmacy is recalling two syringes of Morphine Sulfate 1.5 mg/ml due to a lack of assurance of sterility.
Hartley Medical Center Pharmacy is recalling Morphine Sulfate, Sufentanil Citrate, and Bupivacaine HCL vials due to a lack of assurance of sterility.
Hartley Medical Center Pharmacy is recalling 10 vials of Prolotherapy with Phenol due to non-sterility concerns. The product was distributed in California and Nevada.
Hartley Medical Center Pharmacy is recalling 14 vials of Prolotherapy with Phenol due to non-sterility concerns. The product was distributed in California and Nevada.